Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients
- 15 October 1989
- Vol. 64 (8), 1700-1707
- https://doi.org/10.1002/1097-0142(19891015)64:8<1700::aid-cncr2820640824>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridizationCancer, 1988
- Effects of transcatheter arterial embolization on hepatocellular carcinoma. Analysis by multivariate logistic model and Cox's proportional hazard model.Kanzo, 1987
- Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levelsCancer, 1982
- Primary liver cancers in JapanCancer, 1980
- Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.BMJ, 1978
- Serum alphafetoprotein in hepatocellular carcinomaCancer, 1977
- Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinomaCancer, 1977
- A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patientsCancer, 1975
- Alpha-fetoprotein in primary liver cancer and other diseases.Gut, 1974
- Serum alpha-fetoprotein in 184 ugandan patients with hepatocellular carcinoma.Clinical, laboratory, and histopathologic correlationsCancer, 1974